FIELD: medicine, cellular biology. SUBSTANCE: invention relates to the humanized antibodies that recognize verotoxin II and cell line producing thereof. Invention provides creature of the humanized antibody representing the humanized form of murine antibody VTm.1 that is characterized by variable region of light chain and variable region of heavy chain and that binds and nutrilizes VT2 or its variant specifically. Invention relates also to pharmaceutical compositions and methods for treatment using indicated antibodies. The advantage of invention involves preparing antibodies without immunogenicity for humans but eliciting properties of murine antibody that can be prepared by methods useful for therapeutical application. EFFECT: valuable medicinal and immunological properties of antibodies. 25 cl, 6 tbl, 7 dwg, 12 ex
Title |
Year |
Author |
Number |
HUMAN IMMUNOGLOBULIN SHOWING SPECIFICITY TO HUMAN PROTEIN L-SELECTIN |
1993 |
|
RU2151612C1 |
RECOMBINANT ANTIBODY, POLYNUCLEOTIDE (VARIANTS), METHOD OF PREPARING HEAVY AND/OR LIGHT CHAINS OF RECOMBINANT ANTIBODY (VARIANTS) |
1989 |
- Kehri L.Kvin
- Garol'D Ehdvin Selik
|
RU2126046C1 |
HUMANISED ANTIBODIES SPECIFIC FOR HSP65-DERIVED PEPTIDE-6, METHODS AND USES THEREOF |
2010 |
- Naparstek Yaakov
- Yair Shira
|
RU2596925C2 |
HUMANIZED IMMUNE BODIES IDENTIFYING ALPHA-SINUCLEIN |
2012 |
- Saldankha Khose
- Nijdzhar Tarlochan S.
|
RU2575629C2 |
HUMANISED ANTIBODIES TO LIV-1 AND USE THEREOF FOR TREATING CANCER |
2011 |
- Fang Howard L.
- Sussman Django
- Arthur William
- Nesterova Albina
|
RU2608646C2 |
HUMANIZED ANTIBODIES, WHICH RECOGNIZE ALPHA-SINUCLEIN |
2013 |
- Saldankha Khose
- Nijdzhar Tarlochan S.
|
RU2642262C2 |
HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEINE |
2012 |
- Saldanha Jose
- Nijjar Tarlochan S.
|
RU2743738C2 |
NOVEL ANTI-CLDN18.2 ANTIBODIES |
2020 |
- Tsyan, Syuemin
- Li, Chzhen
- Ten, Fej
- Li, Khuntszyun
- Chaj, Khoj
- Go, Khuankhuan
|
RU2830887C2 |
THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMENTIA |
2013 |
- Mori Khirosi
- Tomiyama Takami
- Matsumoto Eiti
- Eguti Khirosi
- Kunori Yuiti
|
RU2657438C2 |
GENETICALLY MODIFIED ANIMALS OTHER THAN HUMANS FOR PRODUCING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS FOR PRODUCTION AND VERSIONS OF USE THEREOF |
2019 |
|
RU2819525C2 |